Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

  title={Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.},
  author={Matthew J. Hepburn and Mark G Kortepeter and Phillip R. Pittman and Ellen F Boudreau and Joseph A Mangiafico and Peter A. Buck and Sarah L.W. Norris and Edwin L. Anderson},
  volume={24 15},
A retrospective review was conducted of yellow fever vaccination among laboratory workers receiving annual serologic assessment to determine the initial and long-term response after boosting. Patients were divided into three groups based on pre-vaccination serology: Group 1, 1:10; Group 2, 1:20-1:40 and Group 3, >1:40. The percent with > or = four-fold increase in titers after booster vaccination were: 78% (646/829, Group 1), 65% (79/121, Group 2) and 10% (8/79, Group 3) (p<0.0001). The median… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 17 extracted citations

Intradermal Immunization

Current Topics in Microbiology and Immunology • 2012
View 4 Excerpts
Highly Influenced

Is a dose of 17D vaccine in the current context of Yellow Fever enough?

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] • 2018

Yellow fever.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology • 2015


Publications referenced by this paper.
Showing 1-10 of 25 references

Persistence of measles antibody after revaccination.

The Journal of infectious diseases • 1992
View 3 Excerpts
Highly Influenced

, Arilvax

TP Monath, K McCarthy, P Bedford, CT Johnson, R Nichols

Prevention of yellow fever in persons traveling to the tropics.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2002

Similar Papers

Loading similar papers…